Macular degeneration is a medical condition with active clinical research programs worldwide.

14 total trials for this combination

Showing top 10 of 14 trials

Trials

NCT ID	Title	Status	Phase
NCT04567303	Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration	ACTIVE_NOT_RECRUITING	PHASE1/PHASE2
NCT03815825	GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)	COMPLETED	PHASE2
NCT02462486	Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration	COMPLETED	PHASE3
NCT02228304	Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)	TERMINATED	PHASE1/PHASE2
NCT06779773	A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy	RECRUITING	—
NCT06635148	A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)	RECRUITING	PHASE2
NCT00527423	Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD	COMPLETED	PHASE2
NCT00509795	Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)	COMPLETED	PHASE3
NCT05839041	A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)	ACTIVE_NOT_RECRUITING	PHASE2
NCT04435366	A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)	COMPLETED	PHASE3

Related Pages

All Macular degeneration trials All trials in Hagerstown, United States